How should we give progestogen?

Climacteric

Volumn 3, Issue 3, 2000, Pages 153-154

  Sturdee, D W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; LEVONORGESTREL; PHYTOESTROGEN;

EDITORIAL; ENDOMETRIUM CANCER; HORMONE SUBSTITUTION; HUMAN; MENORRHAGIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0033794132     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130008500115     Document Type: Editorial

References (11)

1. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women
2. Adherence to postmenopausal hormone therapy during the year after the initial prescription: A population study
3. Intrauterine application of progestins in hormone replacement therapy: A review
4. The four harms of harmless therapies
5. Advertising standards for complementary medicines at the climacteric
6. The effect of Promensil(®), an isoflavone extract, on menopausal symptoms
7. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women
8. Is there a proven place for phytoestrogens in the menopause?
9. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women
10. Osteoporosis reversal: The role of progesterone
11. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women